Suppr超能文献

肿瘤抑制因子染色质结构域螺旋酶 DNA 结合蛋白 5(CHD5)通过解旋重塑核小体。

The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.

出版信息

J Biol Chem. 2014 Jul 25;289(30):20717-26. doi: 10.1074/jbc.M114.568568.

Abstract

Although mutations or deletions of chromodomain helicase DNA-binding protein 5 (CHD5) have been linked to cancer and implicate CHD5 in tumor suppression, the ATP-dependent activity of CHD5 is currently unknown. In this study, we discovered that CHD5 is a chromatin remodeling factor with a unique enzymatic activity. CHD5 can expose nucleosomal DNA at one or two discrete positions in the nucleosome. The exposure of the nucleosomal DNA by CHD5 is dependent on ATP hydrolysis, but continued ATP hydrolysis is not required to maintain the nucleosomes in their remodeled state. The activity of CHD5 is distinct from other related chromatin remodeling ATPases, such as ACF and BRG1, and does not lead to complete disruption or destabilization of the nucleosome. Rather, CHD5 likely initiates remodeling in a manner similar to that of other remodeling factors but does not significantly reposition the nucleosome. While the related factor CHD4 shows strong ATPase activity, it does not unwrap nucleosomes as efficiently as CHD5. Our findings add to the growing evidence that chromatin remodeling ATPases have diverse roles in modulating chromatin structure.

摘要

虽然染色质螺旋酶 DNA 结合蛋白 5(CHD5)的突变或缺失与癌症有关,并暗示 CHD5 参与肿瘤抑制,但 CHD5 的 ATP 依赖性活性目前尚不清楚。在这项研究中,我们发现 CHD5 是一种具有独特酶活性的染色质重塑因子。CHD5 可以在核小体的一个或两个离散位置暴露核小体 DNA。CHD5 对核小体 DNA 的暴露依赖于 ATP 水解,但不需要继续 ATP 水解来维持重塑状态的核小体。CHD5 的活性与其他相关的染色质重塑 ATP 酶(如 ACF 和 BRG1)不同,不会导致核小体完全破坏或失稳。相反,CHD5 可能以类似于其他重塑因子的方式启动重塑,但不会显著重新定位核小体。虽然相关因子 CHD4 显示出很强的 ATP 酶活性,但它不像 CHD5 那样有效地解开核小体。我们的发现增加了越来越多的证据,表明染色质重塑 ATP 酶在调节染色质结构方面具有多种作用。

相似文献

7
Role of CHD5 in human cancers: 10 years later.CHD5 在人类癌症中的作用:10 年后。
Cancer Res. 2014 Feb 1;74(3):652-8. doi: 10.1158/0008-5472.CAN-13-3056. Epub 2014 Jan 13.
10
The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.染色质重塑因子CHD5是WEE1的转录抑制因子。
PLoS One. 2014 Sep 23;9(9):e108066. doi: 10.1371/journal.pone.0108066. eCollection 2014.

引用本文的文献

2
Chromatin remodellers as therapeutic targets.染色质重塑因子作为治疗靶点。
Nat Rev Drug Discov. 2024 Sep;23(9):661-681. doi: 10.1038/s41573-024-00978-5. Epub 2024 Jul 16.
3
The therapeutic potential of targeting the CHD protein family in cancer.靶向 CHD 蛋白家族治疗癌症的潜力。
Pharmacol Ther. 2024 Apr;256:108610. doi: 10.1016/j.pharmthera.2024.108610. Epub 2024 Feb 15.
6
CHD5 inhibits metastasis of neuroblastoma.CHD5 抑制神经母细胞瘤的转移。
Oncogene. 2022 Jan;41(5):622-633. doi: 10.1038/s41388-021-02081-0. Epub 2021 Nov 17.

本文引用的文献

3
Chd5 requires PHD-mediated histone 3 binding for tumor suppression.Chd5 需要 PHD 介导的组蛋白 3 结合来抑制肿瘤。
Cell Rep. 2013 Jan 31;3(1):92-102. doi: 10.1016/j.celrep.2012.12.009. Epub 2013 Jan 10.
4
Multivalent recognition of histone tails by the PHD fingers of CHD5.CHD5 的 PHD 手指对组蛋白尾部的多价识别。
Biochemistry. 2012 Aug 21;51(33):6534-44. doi: 10.1021/bi3006972. Epub 2012 Aug 8.
10
The biology of chromatin remodeling complexes.染色质重塑复合物的生物学
Annu Rev Biochem. 2009;78:273-304. doi: 10.1146/annurev.biochem.77.062706.153223.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验